Sugi Predict

Sugi Predict / Compounds / SCHEMBL3604932

SCHEMBL3604932

SCHEMBL3604932

Cc1c(NC(=O)NCC(C)(C)CO)c(C)c2c(c1-c1ccccc1)OCC2c1ccc(C(C)C)cc1

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ EPHX1 P07099 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3607031 0.89 ALDH1A1 (0.33) L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL3601765 0.89 EPHX1 (0.32) L3MBTL1ALDH1A1SMN1; SMN2EPHX1
SCHEMBL3604673 0.88 EPHX1 (0.37) L3MBTL1ALDH1A1SMN1; SMN2EPHX1
SCHEMBL3603966 0.87 EPHX1 (0.36) L3MBTL1ALDH1A1SMN1; SMN2EPHX1KDM4E
SCHEMBL3606491 0.86 ALDH1A1 (0.34) L3MBTL1ALDH1A1SMN1; SMN2EPHX1
SCHEMBL3605234 0.85 ALDH1A1 (0.34) L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL3587470 0.84 SMN1; SMN2 (0.34) L3MBTL1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL3601246 0.78 POLB (0.35) L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL3595290 0.77 MAPT (0.33) L3MBTL1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL3607378 0.77 L3MBTL1 (0.33) L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1637527-B1 CANNABINOID RECEPTOR MODULATOR TAKEDA PHARMACEUTICAL (JP) 2013-04-17 — — EP disclosed
US-20100240743-A1 CANNABINOID RECEPTOR MODULATOR TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-09-23 — — US disclosed
US-7507841-B2 Carbamoylamino-substituted 2,3-dihydro-benzofurans, indoles and benzothiophenes, e.g., (+)-N-((3R)-3-(4-isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide; cerebrovascular disorders TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-03-24 — — US disclosed
US-20090023800-A1 Cannabinoid receptor modulator TAKEDA PHARMACEUTICAL COMPANY LIMITED 2009-01-22 — — US disclosed
US-7465815-B2 Cannabinoid receptor modulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-16 — — US disclosed
US-20080021087-A1 Cannabinoid receptor modulator TAKEDA PHARMACEUTICAL COMPANY LIMITED 2008-01-24 — — US disclosed
US-20070099990-A1 Cannabinoid receptor modulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-05-03 — — US disclosed
EP-1637527-A1 CANNABINOID RECEPTOR MODULATOR Takeda Pharmaceutical Company Limited (JP) 2006-03-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240743-A1 CANNABINOID RECEPTOR MODULATOR CNR1, CNR2, GPR18 L3MBTL1 3559/4885ALDH1A1 1463/4885SMN1; SMN2 4180/4885
US-20080021087-A1 Cannabinoid receptor modulator CNR1, CNR2, GPR18 L3MBTL1 3559/4885ALDH1A1 1463/4885SMN1; SMN2 4180/4885
US-20090023800-A1 Cannabinoid receptor modulator CNR1, CNR2, GPR18 L3MBTL1 3559/4885ALDH1A1 1463/4885SMN1; SMN2 4180/4885
US-20070099990-A1 Cannabinoid receptor modulator CNR1, CNR2, GPR18 L3MBTL1 3559/4885ALDH1A1 1463/4885SMN1; SMN2 4180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.